Educational Activities in Oncology

1.0 CME/MOC/NCPD/CE/AAPA/IPCE
August 29, 2024
Exchanging Ideas on How to Navigate Patient-Centric Clinical Decisions in Integration of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
Chair
Hope S. Rugo, MD, FASCO
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California
Chair
Sarah Donahue, MPH, NP, AOCNP
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California
Patient
Holly Hernandez
0.5 CME/NCPD/AAPA/IPCE
June 26, 2024
On Target: Integrating Trop-2-Directed Therapeutics for Urothelial Carcinoma With Precision
Chair
Petros Grivas, MD, PhD
University of Washington
Fred Hutchinson Cancer Center
Seattle, Washington
Patient
Paul Weaver
1.0 NCPD/ILNA/AAPA
May 9, 2024
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education
Chair
Jamie Carroll, APRN, CNP, MSN
Mayo Clinic
Rochester, Minnesota
1.0 CME
March 14, 2023
The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes
Co-Chair & Moderator
James M. Foran, MD, FRCPC
Mayo Clinic Cancer Center
Jacksonville, Floridas
Co-Chair & Presenter
Jessica K. Altman, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
1.0 CME/MOC
February 27, 2023
Perfecting Precision in Modern NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?
Chair & Presenter
Stephen V. Liu, MD
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC
Presenter
Ibiayi Dagogo-Jack, MD
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts
1.0 CME/MOC
February 24, 2023
Peer Pressure: How Well Do You Know Your ADCs? Answers to Key Questions About Antibody–Drug Conjugates in NSCLC?
Chair & Presenter
Benjamin Levy, MD
Johns Hopkins School of Medicine
Johns Hopkins Sidney Kimmel Cancer Center (SKCC) at Sibley Memorial Hospital
Washington, District of Columbia
Presenter
Melissa L. Johnson, MD
Sarah Cannon Research Institute
Nashville, Tennesse
Presenter
Stephen V. Liu, MD
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, District of Columbia
Presenter
Christine M. Lovly, MD, PhD
Vanderbilt University Medical Center
Vanderbilt Ingram Cancer Center
Nashville, Tennessee
1.5 CME/MOC
February 17, 2023
Fresh Perspectives on Moving Toward Personalized Care for Bladder Cancer: Tips, Tools, and Strategies for Leveraging the Latest Advancements Across the Disease Spectrum
Chair & Presenter
Matthew I. Milowsky, MD, FASCO
University of North Carolina at Chapel Hill
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
Presenter
Shilpa Gupta, MD
Taussig Cancer Institute, Cleveland Clinic
Cleveland, Ohio
Presenter
Andrea Necchi, MD
Vita-Salute San Raffaele University
IRCCS San Raffaele Hospital
Milan, Italy
1.5 CME/MOC
December 9, 2022
The Rising Tide of CAR-T in Lymphoma: Guidance on Leveraging Cellular Therapy to Improve Outcomes Across the Spectrum of Care
Chair
Jason Westin, MD, MS, FACP
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Presenter
Alison R. Sehgal, MD
University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania
1.5 CME/MOC
December 9, 2022
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Chair & Presenter
Guillermo Garcia-Manero, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas
Presenter
Joseph D. Khoury, MD, FCAP
University of Nebraska Medical Center
Omaha, Nebraska
Presenter
Aditi Shastri, MD
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York
2.0 CME/MOC
December 6, 2022
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
Chair & Presenter
Erika Hamilton, MD
Sarah Cannon Research Institute/Tennessee Oncology
Nashville, Tennessee
Presenter
William J. Gradishar, MD, FASCO, FACP
Maggie Daley Center for Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Presenter
Hope S. Rugo, MD, FASCO
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California
Presenter
Professor Peter Schmid, FRCP, MD, PhD
Centre for Experimental Cancer Medicine
Bart's Cancer Institute, Queen Mary University of London
London, England, United Kingdom
1.0 CME/MOC
November 16, 2022
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments
Chair & Presenter
Professor Peter Schmid, FRCP, MD, PhD
Centre for Experimental Cancer Medicine
Bart's Cancer Institute, Queen Mary
University of London
London, England, United Kingdom
Presenter
Carlos H. Barrios, MD
Latin American Cooperative Oncology Group (LACOG)
Porto Alegre, Brazil
Presenter
Eva M. Ciruelos, MD, PhD
University Hospital 12 de Octubre
HM Hospitales
Complutense University of Madrid
Madrid, Spain
Presenter
Hope S. Rugo, MD, FASCO
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California
0.75 CME/MOC/NCPD/IPCE
October 27, 2022
Clinical Conundrums in Pretreated Metastatic Urothelial Carcinoma: Improving Patient Outcomes With Novel Antibody-Drug Conjugates
Chair & Presenter
Scott T. Tagawa, MD, MS, FACP
Meyer Cancer Center
Weill Cornell Medicine
New York, New York
Presenter
Amie Patel, RN, BSN, MS, CCRC
Meyer Cancer Center
Weill Cornell Medical Center
New York Presbyterian Hospital
New York, New York
Patient
Rosario Ardizzone
0.75 CME/MOC/NCPD
June 23, 2022
Candid Conversations and Clinical Consults in Community Context: Practical Guidance for Integrating TROP2-Targeting ADCs Into Patient-Centric Breast Cancer Clinical Care
Chair & Presenter
Aditya Bardia, MD, MPH
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts
Presenter
Maria Shellock, RN, BSN
Massachusetts General Hospital
Cancer Center Protocol Office
Boston, Massachusetts
Presenter
Erika Hamilton, MD
Sarah Cannon Research Institute/Tennessee Oncology
Nashville, Tennessee
Patient
Melissa Edson
1.0 CME
May 25, 2022
CAR-T Cell Therapy: Are You Up to the Challenge? New Evidence and Best Practices Driving Modern Cellular Therapies as a Standard of Care for Leukemia and Lymphoma
Chair & Presenter
Michael R. Bishop, MD
The David and Etta Jonas Center for Cellular Therapy
University of Chicago
Chicago, Illinois
Presenter
Shannon L. Maude, MD, PhD
The Children's Hospital of Philadelphia
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Presenter
Peter A. Riedell, MD
The David and Etta Jonas Center for Cellular Therapy
University of Chicago
Chicago, Illinois